课题基金 / 基金详情

CONFORMATIONALLY RESTRICTED SYNTHETIC AIDS VACCINE

CONFORMATIONALLY RESTRICTED SYNTHETIC AIDS VACCINE
构象限制的合成艾滋病疫苗
批准号:
2074275
负责人:
ARNOLD Chase SATTERTHWAIT
金额:
$27.06万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-12-01 至 1997-11-30

项目摘要

项目成果

ARNOLD Chase SATTERTHWAIT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A major challenge for the subunit vaccine approach to AIDS is the induction of broadly cross-reactive neutralizing antibodies. Recent human trials with recombinant glycoprotein 120 vaccines indicate that many as yet undefined problems lie ahead. On the other hand, a few conformationally sensitive monoclonal antibodies have been identified including those cloned from infected individuals demonstrating that a natural origin for potent, broadly cross-reactive neutralizing responses in humans exists. Our proposal is directed to the identification of synthetic peptide mimetics corresponding to epitopes defined by these antibodies. for this work, we will rely on new procedures developed in our laboratory for folding peptides with covalent hydrogen bond.mimics. A strong structural group at TSRI will collaborate on this project for structure prediction, and X-ray crystallography. Mimetics will be incorporated into MAPS with "universal" T-cell epitopes and their immunogenicity evaluated in animals. HIV-I neutralization assays will be carried out by our collaborators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Leukemias with Bcl2 BH3 Helical Peptides
Targeting Leukemias with Bcl2 BH3 Helical Peptides
A Structure based Serological Test for Cervical Cancer
A Structure based Serological Test for Cervical Cancer
海外基金